EDWARDS LIFESCIENCES CORP (EW)

Company Profile

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. The company is headquartered in Irvine, California and currently employs 17,300 full-time employees. The company went IPO on 2000-03-27. The firm's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. The company also develops hemodynamic and noninvasive brain and tissue oxygenation monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including the Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease. The company conducts operations worldwide and is managed in various geographical regions, including the United States, Europe, Japan, and the Rest of the World. The company sells products that are used to treat advanced cardiovascular disease in all regions.

Company Info

EDWARDS LIFESCIENCES CORP

One Edwards Way

Irvine CALIFORNIA 92614

P: 19492502500

CEO: Michael A. Mussallem

Employees: 17300

Website: https://www.edwards.com